By Tony Fong

SAN FRANCISCO (GenomeWeb News) — As Danaher proceeds with the integration of Beckman Coulter, there is "a lot of work still to do in quality and innovation," but progress has been made, Danaher CEO Larry Culp said at the JP Morgan Healthcare Conference here today.

And while the Beckman Coulter business may not improve substantially over a flattish 2011, momentum can be built this coming year into 2013, Culp said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.